scholarly article | Q13442814 |
P356 | DOI | 10.1016/J.UROLOGY.2012.08.112 |
P698 | PubMed publication ID | 23374803 |
P2093 | author name string | Richard G Stock | |
Nelson N Stone | |||
Michael Buckstein | |||
Todd J Carpenter | |||
P2860 | cites work | Comparative analysis of prostate-specific antigen free survival outcomes for patients with low, intermediate and high risk prostate cancer treatment by radical therapy. Results from the Prostate Cancer Results Study Group | Q27011661 |
Physician visits prior to treatment for clinically localized prostate cancer. | Q34610617 | ||
Impact of age at diagnosis on prostate cancer treatment and survival | Q34679220 | ||
Race independently predicts prostate specific antigen testing frequency following a prostate carcinoma diagnosis | Q35184342 | ||
Treatment decision-making for localized prostate cancer: what younger men choose and why. | Q36182162 | ||
Prostate brachytherapy and second primary cancer risk: a competitive risk analysis. | Q45032576 | ||
Prevalence and risk factors for erectile dysfunction in the US. | Q45225557 | ||
Health-related quality of life up to six years after (125)I brachytherapy for early-stage prostate cancer | Q48374059 | ||
Long-term toxicity and quality of life up to 10 years after low-dose rate brachytherapy for prostate cancer. | Q48607920 | ||
Biologically effective dose values for prostate brachytherapy: effects on PSA failure and posttreatment biopsy results. | Q51961427 | ||
Assessment of postbrachytherapy sexual function: a comparison of the IIEF-5 and the MSEFS. | Q53242116 | ||
Quality of life and satisfaction with outcome among prostate-cancer survivors | Q80917895 | ||
Long-term results of an RTOG Phase II trial (00-19) of external-beam radiation therapy combined with permanent source brachytherapy for intermediate-risk clinically localized adenocarcinoma of the prostate | Q83437107 | ||
Long-term potency preservation following brachytherapy for prostate cancer | Q84461485 | ||
10-year experience with I-125 prostate brachytherapy at the Princess Margaret Hospital: results for 1,100 patients | Q84626494 | ||
Long-term urinary, sexual, and rectal morbidity in patients treated with iodine-125 prostate brachytherapy followed up for a minimum of 5 years | Q94515819 | ||
P433 | issue | 2 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | adenocarcinoma | Q356033 |
brachytherapy | Q896687 | ||
prostate adenocarcinoma | Q18555107 | ||
P304 | page(s) | 364-368 | |
P577 | publication date | 2013-02-01 | |
P1433 | published in | Urology | Q7900884 |
P1476 | title | Long-term outcomes and toxicity in patients treated with brachytherapy for prostate adenocarcinoma younger than 60 years of age at treatment with minimum 10 years of follow-up | |
P478 | volume | 81 |
Q38356515 | A review of detrusor overactivity and the overactive bladder after radical prostate cancer treatment |
Q36276830 | Comparison of permanent (125)I seeds implants with two different techniques in 500 cases of prostate cancer |
Q48543708 | Does supplemental external beam radiation therapy impact urinary, bowel, and erectile function following permanent prostate brachytherapy?: results of two prospective randomized trials |
Q95503798 | Editorial comment |
Q35174871 | Hematuria following stereotactic body radiation therapy (SBRT) for clinically localized prostate cancer |
Q30395537 | In vivo visualization of prostate brachytherapy seeds with photoacoustic imaging |
Q35005250 | Iodine-125 induces apoptosis via regulating p53, microvessel density, and vascular endothelial growth factor in colorectal cancer |
Q41478724 | Long term outcome and side effects in patients receiving low-dose I125 brachytherapy: a retrospective analysis |
Q48187737 | Long-term oncological outcomes and toxicity in 597 men aged ≤60 years at time of low-dose-rate brachytherapy for localised prostate cancer |
Q47209706 | Long-term outcomes in patients younger than 60 years of age treated with brachytherapy for prostate cancer |
Q49177979 | Quality of life after low-dose rate-brachytherapy for prostate carcinoma - long-term results and literature review on QLQ-C30 and QLQ-PR25 results in published brachytherapy series |
Q30746543 | Second primary cancers after radiation for prostate cancer: a systematic review of the clinical data and impact of treatment technique |
Q43888431 | Urinary Incontinence Following Prostate Brachytherapy |